Presentation is loading. Please wait.

Presentation is loading. Please wait.

Use Of Immobilised Artificial Membrane (IAM) Chromatography with Aqueous and simulated intestinal fluid as mobile phase David Sherwood NOV 2006.

Similar presentations


Presentation on theme: "Use Of Immobilised Artificial Membrane (IAM) Chromatography with Aqueous and simulated intestinal fluid as mobile phase David Sherwood NOV 2006."— Presentation transcript:

1 Use Of Immobilised Artificial Membrane (IAM) Chromatography with Aqueous and simulated intestinal fluid as mobile phase David Sherwood NOV 2006

2 IAM Alternative to LogD Uses Phosphatidycholine (PC) embedded in silica as stationary phase PC analogs closely mimic the surface of biological cell membranes IAM more closely mimic the interactions of analytes with biological membranes, where hydrophobic, ion pairing and hydrogen bonding interactions are possible IAM pH7.4 being developed in Cambridge based on method developed by colleagues in Braine

3 IAM stationary phase

4 IAM pH7.4 General Procedure AT UCB 1mg of sample dissolved in 1ml MeOH and filtered Hydrophilic compounds 1 isocratic run in 100%PBS pH7.4 Lipophilic 5 isocratic HPLC runs per sample using pH7.4 PBS as mobile phase in 5 different %MeCN (15%, 20%, 25%, 30%, 35%) extrapolate back to 0% MeCN Take the Log value of the intercept Log KIAM is therefore quoted as being in 100% pH7.4 PBS Calculate Capacity factor KIAM Tr.-To kIAM = To Tr.: retention time of the compound To: void volume, the retention time of a product that is not retained on the column, NaNO2 in our case

5 Extrapolation Log kIAM 1.91

6 Correlation Of KIAM with other Data Jean-Philippe Starck, Patrice Talaga, Luc Que´re´et.al, Potent anti- muscarinic activity in a novel series of quinuclidine derivatives Bioorganic & Medicinal Chemistry Letters 16 (2006) 373–377 Suggest that IAM can be an effective tool in predicting metabolic clearance providing structure is taken into consideration Ferenc Hollosy, Klara Valko, Anne Hersey et. al Estimation of Volume of Distribution in Humans from High Throughput HPLC- Based Measurements of Human Serum Albumin Binding and Immobilized Artificial MembranePartitioning J. Med. Chem. 2006, 49, Have suggested a way of estimating Volume distribution using IAM and HAS for Acids Bases and zwitterions

7 Log KIAM Vs Metabolic Clearance (series of compounds with similar structure) N=8 Note that this correlation suggests the reverse of what We would expect

8 IAM Vs Clearance (Same series more data points) N=12 Posses the question how many data points required to prove correlation

9 IAM v Target Cell potency N=6

10 Target protein potency N=6

11 IAM Fessif Fessif mobile phase Fed State Simulated Intestinal Fluid composition according to Dressman et al.,1998. Dissolution testing as a prognostic tool for oral absorption: immediate release dosage forms. Pharm. Res. 15, pH 5.0 Buffer: Dissolve 4.04 g of NaOH, 8.65 g of CH 3 COOH 100% and g of KCl and sufficient water to make 1000 ml. Adjust to pH 5.0 with HCl or NaOH 1M if necessary. Fessif: Dissolve 6.6 g of Taurocholic Acid in 50 ml of buffer pH 5.0. Add 2.36g lecithin add stirrer bar place on stirrer over night. add sufficient pH5.0 buffer to make 800 ml.

12 Fessif KIAM has been reasonably correlated with many in-vitro permeability studies But we make drugs for humans so the earlier we model in-vitro permeability on Human in-vivo the better Also most permeability assays are performed in aqueous buffer, but the intestinal juices are more complex than that and may influence permeability Aim of KIAM Fessif was to see if it could be correlated to human permeability and was there a significant difference to using Aq buffer

13 N=17

14 Fessif KIAM For low lipophilic compounds use 100% fessif mobile phase similar to that of IAM ph7.4 Extrapolations in varying degrees of MeCN cannot be used as mobile phase crashes MeOH has been tried to no success At the moment it is not feasible to analyse compounds above LogKIAM 0.5 (Fessif) so correlation of 17 broad spectrum standards with intestinal absorption is not possible However, differences have been noted between Fessif pH5.0 and Aq pH5.0

15 LogKFessif vs Human Effective permeability (Peff) N=6 Correlation is non existent however Only the low KIAM were able to be tested

16 Log kIAM pH5 vs Human Effective Permeability (Peff) N=6

17 logK IAM from Fessif Vs Aq pH5.0 mobile phase N=6 Some variation between fessif and aq pH5.0 may suggest Bile surfactants and lipids have an impact on Compound interactions with PC stationary phase And thus may influence permeability

18 Summary At Cambridge we are only beginning to utilise IAM We want KIAM pH7.4 and KIAM Fessif to be meaningful not just more data to go unnoticed KIAM pH7.4 has been reported by many sources including colleagues in Braine to have correlation with some compound series and clearance providing structure is taken into concideration. KIAM pH5- pH6.8 has been correlated with in-vitro permeability methods which may not be good enough should be correlated with in- vivo human Early data suggest that bile surfactants and lipids may have influence on how compounds interact with biological membranes I believe that the use of fessif in KIAM and in-vitro permeability studies may be the way forward

19 Aknowledgements Luc Quere, Ariane Descamps, Géraldine Longfils Sandrine Rome, at UCB Braine for their support and assistance


Download ppt "Use Of Immobilised Artificial Membrane (IAM) Chromatography with Aqueous and simulated intestinal fluid as mobile phase David Sherwood NOV 2006."

Similar presentations


Ads by Google